|
Human
Genome Sciences, Inc
|
Nasdaq:
HGSI
NASDAQ
100
Human
Genome Sciences, Inc. is a genomics and biopharmaceutical company focused
on therapeutic product development and functional analysis of genes using
its proprietary technology platform. The Company discovers, develops and
intends to commercialize novel compounds for treating and diagnosing human
disease based on the identification and study of genes.
9410 Key West Avenue
Rockville, MD 20850
Phone: (301) 309-8504
Fax: (301) 309-8512
|